Murray M.Fisher
TRIUMPH-1 Phase 3 Trial Results (May 2026) On May 21, 2026, Eli Lilly announced topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial for retatrutide
1% Blue Copper Peptide (GHK-Cu): A powerhouse peptide that promotes collagen synthesis and repairs damaged cells
Intracellular water-specific MR of microbead-adherent cells: the HeLa cell intracellular water exchange lifetime
Because the L-glutathione is encapsulated in a protective fat layer, it bypasses much of the digestive irritation associated with standard powders
Sources: Sonthalia et al., Indian J Dermatol Venereol Leprol 2016 , Sonthalia et al., Dermatol Pract Concept 2018 , Narrative review, 2025 Global & Indian Trends (2024): Glutathione-based skin lightening treatments are part of a $10+ billion global skincare market India saw a 35% rise in demand for skin-brightening injectables over the past two years Increasing popularity among both men and women aged 18 to 45 Source: ISAPS Global Survey 2024 Dr